RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides

Sponsor
Assistance Publique - Hôpitaux de Paris
Study ID
NCT00307593
Status
Completed

Conditions

  • Churg-Strauss Syndrome
  • Microscopic Polyangiitis
  • Wegener's Granulomatosis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Infliximab — DRUG
    Infliximab
  • Rituximab — DRUG
    Rituximab

Study Details

The purpose of this study is to compare a 2 immunosuppressant regimen for the treatment of relapsing or refractory necrotizing antineutrophil cytoplasmic antibody (ANCA) associated vasculitides.

Key Dates

Start date
May 31, 2004
Status verified
Mar 2007
Completion
Jun 30, 2007

Study Design

Enrollment
20 participants (actual)
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT

Arms

  • Active Comparator: 1
    Rituximab
  • Active Comparator: 2
    Infliximab

Primary Outcome Measure

Partial or complete remission of the vasculitides [ Time Frame: one year ]

Related Studies